About NSGC

2020 Premier Sponsors

NSGC gratefully acknowledges our Premier Sponsors who support NSGC throughout the year, making many NSGC Programs possible. These programs provide valuable education to genetic counselors and foster research for the betterment of our profession. We thank the following Premier Sponsors for their generous support.

 

Diamond Level

Invitae Logo.png

Invitae’s mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for everyone. We offer high-quality, affordable testing across all of life’s stages. Visit www.invitae.com and follow us on Twitter @Invitae.

Platinum Level

Ambry_KM_logo_rgb_0219New_WEB.png

Ambry Genetics is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. Ambry is an established leader in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy, unparalleled service, and responsibly applying new technologies to the clinical molecular diagnostics market. For more information about Ambry Genetics, visit ambrygen.com.

AZ_RGB_H_COL.PNG

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

         

  

Avrobio-Logo_RGB.jpg

About AVROBIO
Our mission is to free people from a lifetime of genetic disease with a single dose of gene therapy. We aim to halt or reverse disease throughout the body by driving durable expression of functional protein, even in hard-to-reach tissues and organs including the brain, muscle and bone. Our clinical-stage programs include Fabry disease, Gaucher disease and cystinosis and we also are advancing a program in Pompe disease. AVROBIO is powered by the plato™ gene therapy platform, our foundation designed to scale gene therapy worldwide. We are headquartered in Cambridge, Mass., with an office in Toronto, Ontario. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.

Gold Level

Bluebird-Logo-Full-Color_w-RECODE (002).jpg

At bluebird bio, our goal is to recode the science, the system – and even the status quo – for life. 

We’re working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases. Powered by multiple labs, in-house lentiviral vector manufacturing capabilities and future drug product production, we push ourselves to find answers for the people who need them by exploring the cutting-edge spectrum of gene therapy.

https://www.bluebirdbio.com/

PKI - Genomics _ sidebyside (002).png

PerkinElmer Genomics is a state-of-the-art biochemical and molecular genetics laboratory that provides newborn screening and genomic testing services around the world. With over 7.5 million newborns screened since 1994, our laboratory pairs decades of newborn screening experience with a leading-edge clinical genomics program to offer one of the world’s most comprehensive programs for detecting clinically significant genomic changes. Visit us at www.perkinelmergenomics.com, or follow us on Twitter @PKIGenomics.

Silver Level

Amicus_logo_286c_284c-01.jpg 

Amicus Therapeutics is a global biotechnology company at the forefront of therapies for rare and orphan diseases. The Company has a robust pipeline of advanced therapies for a broad range of human genetic diseases.

NAT_logo_Color_RGB.png 300 ppi.png


Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide by harnessing the power of DNA from a single blood sample to improve the management of reproductive health, cancer and organ transplants. For more information, visit natera.com. Follow Natera on LinkedIn.  

Annotation 2020-05-06 104213.png

Empowering you with innovative reproductive health solutions, from carrier screening to preimplantation genetic testing and prenatal and postnatal applications to help positively impact families around the world. 

www.thermofisher.com/carrierseq

NSGC Executive Office   |   330 North Wabash Avenue, Suite 2000, Chicago, IL 60611   |   312.321.6834   |   nsgc@nsgc.org
© 2020 National Society of Genetic Counselors   |   Privacy Policy   |   Disclaimer   |   Terms and Conditions   |   DMCA Procedures for Removal